Strides Arcolab surges on receiving US FDA approval for its Italian Semi-solids and Oinment facility

18 Sep 2013 Evaluate

Strides Arcolab is currently trading at Rs. 877.75, up by 30.75 points or 3.63% from its previous closing of Rs. 847.00 on the BSE.

The scrip opened at Rs. 858.50 and has touched a high and low of Rs. 887.00 and Rs. 858.50 respectively. So far 31,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1224.90 on 05-Dec-2012 and a 52 week low of Rs. 552.65 on 01-Aug-2013.

Last one week high and low of the scrip stood at Rs. 931.00 and Rs. 839.00 respectively. The current market cap of the company is Rs. 5,187 crore.

The promoters holding in the company stood at 27.39% while Institutions and Non-Institutions held 59.81% and 12.80% respectively.

Strides Arcolab has received US FDA approval for Beltapharm's facility at Milan, Italy. This state-of-the-art, EU and TGA (Australia) approved facility located in Milan, Italy, manufactures liquids, semi-solids, ointments and creams. The Company is expecting its first approval of a niche semisolid product by Q1 2014. Strides is developing a portfolio of liquids and semi-solids products for the US and EU markets and currently has over 12 products at various stages of development/approvals. Strides already sell semi-solids in the UK market.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×